1-4 of 4
Mordechai Shtalrid, MD
Close
Sort by
Journal Articles

Evaluation of Novel S-Allyl Derivatives of 6-Mercapto-Purine against B-CLL: Combining the Effects of Different Compounds in A Single Molecule.

Fabian David Arditti, PhD, Mordechai Shtalrid, MD, Lucette Bassous, Lev Shvidel, MD, Alain Berrebi, MD, Talia Miron, PhD
Journal: Blood
Blood (2009) 114 (22): 3437.
https://doi.org/10.1182/blood.V114.22.3437.3437
Published: 2009
Journal Articles

The Significance of Elevated Beta 2-Microglobulin (b2-m) in B-CLL: Evidence of in Vitro b2-m Secretion Following Activation of B-CLL Cells.

Alain Berrebi, MD, Lev Shvidel, MD, Fabian David Arditti, PhD, Lucette Bassous, Michal Haran, Mordechai Shtalrid, MD
Journal: Blood
Blood (2009) 114 (22): 4380.
https://doi.org/10.1182/blood.V114.22.4380.4380
Published: 2009
Journal Articles

Predictive Factors to Hypogammaglobulinemia and Non-Neutropenic Infection Complications after Rituximab/Chemotherapy Treatment

Kalman Filanovsky, MD, Lev Shvidel, MD, Mordechai Shtalrid, MD, Michal Haran, MD, Adrian Duek, MD, Alain Berrebi
Journal: Blood
Blood (2007) 110 (11): 1288.
https://doi.org/10.1182/blood.V110.11.1288.1288
Published: 2007
Journal Articles

Down-Regulation of Activin A by Lymphoma: A Possible Mechanism of Bone Marrow Involvement.

Michal Z. Haran, MD, Reshmi Parameswaran, Edit Feldberg, MD, Mina Fogel, PhD, Monica Huszar, MD, Alain Berrebi, MD, Mordechai Shtalrid, MD, Lev Shvidel, MD, Adrian Duek, MD, Merav Leiba, PhD, Arnon Nagler, MD, Dov Zipori, PhD
Journal: Blood
Blood (2005) 106 (11): 4669.
https://doi.org/10.1182/blood.V106.11.4669.4669
Published: 2005